Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NGEN.VN | EPRX.TO | HELP.NE | ||
| Company | Nervgen Pharma Corp | Eupraxia Pharmaceuticals Inc | Cybin Inc. | ||
| Price Information | |||||
| Exchange | TSX Venture | TSX | Cboe CA | ||
| Open | 4.950 | 10.40 | 7.1300 | ||
| High | 5.230 | 10.40 | 7.1300 | ||
| Low | 4.930 | 9.84 | 6.8400 | ||
| Latest | 5.150 | 9.84 | 6.9900 | ||
| Change | +0.150 | -0.61 | -0.1500 | ||
| % Change | +3.00% | -5.84% | -2.10% | ||
| Volume | 66,939 | 41,064 | 9,238 | ||
| 20-Day Average Volume | 49,920 | 42,805 | 33,223 | ||
| Previous Close | 5.000 | 10.45 | 7.1400 | ||
| Industry | TSX Biotechnology | TSX Biotechnology | N/A | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 5.554 | 10.09 | 7.2670 | ||
| 20-Day Raw Stochastic | 23.73% | 23.03% | 18.42% | ||
| 20-Day Relative Strength | 42.10 | 47.12 | 46.01 | ||
| Weighted Alpha | +39.45 | +60.98 | N/A | ||
| Today's Opinion | 8% Buy | 8% Buy | N/A | ||
| Previous Opinion | 24% Buy | 56% Buy | N/A | ||
| Last Month's Opinion | 40% Buy | 24% Buy | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.20% since 03/09/26 | -3.71% since 05/07/26 | -3.71% since 05/07/26 | ||
| Low | 4.870 on 03/13/26 | 9.87 on 05/14/26 | 6.8100 on 05/13/26 | ||
| High | 5.700 on 03/10/26 | 10.77 on 05/13/26 | 7.3700 on 05/11/26 | ||
| 1-Month | |||||
| %Chg | -10.28% since 02/13/26 | -1.40% since 04/14/26 | -7.89% since 04/14/26 | ||
| Low | 4.870 on 03/13/26 | 9.52 on 04/21/26 | 6.6500 on 04/21/26 | ||
| High | 6.050 on 02/23/26 | 11.04 on 05/01/26 | 8.5500 on 04/20/26 | ||
| 3-Month | |||||
| %Chg | -11.21% since 12/16/25 | -14.02% since 02/13/26 | -16.17% since 02/13/26 | ||
| Low | 4.870 on 03/13/26 | 9.11 on 04/08/26 | 5.9000 on 03/31/26 | ||
| High | 8.490 on 01/08/26 | 11.90 on 02/20/26 | 11.6100 on 03/04/26 | ||
| 6-Month | |||||
| %Chg | +38.07% since 09/16/25 | +6.13% since 11/14/25 | N/A since 01/05/26 | ||
| Low | 3.200 on 11/06/25 | 8.06 on 12/04/25 | 5.9000 on 03/31/26 | ||
| High | 8.490 on 01/08/26 | 12.86 on 01/21/26 | 12.1200 on 01/05/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 407,944 | 642,708 | 356,312 | ||
| Shares Outstanding, K | 79,213 | 61,503 | 49,894 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -44,117,305 | -38,576,143 | -79,055,419 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -26,908,856 | -16,711,252 | -42,668,000 | ||
| 60-Month Beta | 0.54 | 1.48 | 0.24 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 11/24/25 | -0.37 | -1.00 on 02/13/26 | ||
| Earnings Date | N/A | N/A | N/A | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | N/A | N/A | ||